<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
(Amendment No. 1)1
NEXTHEALTH, INC.
-------------------------
(Name of Issuer)
Common Stock
-------------------------------------------
(Title of Class of Securities)
653336105
--------------------------
(CUSIP Number)
Steven M. Kolow, c/o Robert Weinstein, Esq.,
Kassler & Feuer, P.C., 101 Arch Street,
Boston, Massachusetts 02110, Telephone No.: (617) 439-3800
- -----------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
May 18, 1999
----------------------------------------------------
(Date of Event Which Requires Filing of This Statement
<PAGE> 2
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition that is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box / /
Note. Schedules filed in paper format shall include a signed original
and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for
other parties to whom copies are to be sent.
(Continued on following pages)
Page 1 of 5 Pages
- ----------------
(1)The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE> 3
SCHEDULE 13D
- -------------------- (Amendment 1) -----------------
CUSIP No. 653336105 13D Page 2 of 5 Pages
- -------------------- -----------------
================================================================================
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Steven M. Kolow
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)/ /
(b)/ /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(d) or 2(e) / /
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
873,400
NUMBER OF ---------------------------------------
SHARES 8 SHARED VOTING POWER
BENEFICIALLY 0
OWNED BY ---------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING 873,400
PERSON WITH ---------------------------------------
10 SHARED DISPOSITIVE POWER
0
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
873,400
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES * / /
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.21%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON *
IN
- --------------------------------------------------------------------------------
* SEE INSTRUCTIONS BELOW BEFORE FILLING OUT!
<PAGE> 4
SCHEDULE 13D Page 3 of 5 Pages
(Amendment 1)
Item 1. Security and Issuer.
This statement relates to the common stock, par value $.01 per share
(the "Common Stock" or "NextHealth Common Stock"), of NextHealth, Inc., a
Delaware corporation (the "Issuer"). The address of the Issuer's principal
executive offices is 16600 N. Lago Del Oro Parkway, Tucson, Arizona 85739.
Item 2. Identity and Background.
(a) The name of the person filing this statement is Steven M. Kolow
("Mr. Kolow","Kolow" or "Purchaser").
(b) Mr. Kolow's residence address is P.O. Box 5360, Wayland,
Massachusetts 01778.
(c) Mr. Kolow's present, principal occupation is that of an
entrepreneur.
(d) Mr. Kolow was not, during the last five years, convicted in a
criminal proceeding (excluding traffic violations or similar
misdemeanors).
(e) Mr. Kolow was not, during the last five years, a party to a
civil proceeding of a judicial or administrative body of
competent jurisdiction and as a result of such proceeding was
or is subject to a judgment, decree or final order enjoining
future violations of, or prohibiting or mandating activities
subject to, Federal or State securities laws or finding any
violation with respect to such laws.
(f) Mr. Kolow is a citizen of the United States of America.
Item 3. Source and Amount of Funds or Other Consideration.
The shares of Common Stock subject to this filing (the "Shares") were
purchased using Mr. Kolow's personal funds. Since the filing of Mr. Kolow's
Schedule 13D on April 11, 1996, Mr. Kolow has purchased 273,400 shares of
Common Stock for an aggregate purchase price (including commissions) of
$272,632.08.
<PAGE> 5
Page 4 of 5 Pages
Item 5. Interest in Securities of the Issuer.
(a) Mr. Kolow beneficially owns 873,400 shares of Common Stock,
which amount represents 10.21% of the Issuer's outstanding
shares of Common Stock. The percentage of Common Stock
outstanding was calculated based upon information contained in
the Issuer's Form 10-Q for the quarterly period ended March 31,
1999.
(b) Number of shares of Common Stock to which Mr. Kolow has:
<TABLE>
<S> <C>
(i) Sole power to vote or to direct the vote: 873,400
(ii) Shared power to vote or to direct the vote: 0
(iii) Sole power to dispose or to direct the disposition: 873,400
(iv) Shared power to dispose or to direct the disposition: 0
</TABLE>
(c) During the past sixty (60) days, Mr. Kolow has purchased
shares of the Common Stock on the open market as follows:
<TABLE>
<CAPTION>
Price Per Share
Trade Date Number of Shares Excluding Commissions
---------- ---------------- ---------------------
<S> <C> <C>
April 20, 1999 5,000 $ 1 7/32
April 20, 1999 5,000 $ 1 3/16
April 20, 1999 5,000 $ 1 5/32
May 18, 1999 40,000 $ 29/32
May 18, 1999 50,000 $ 7/8
May 18, 1999 140,000 $ 31/32
May 20, 1999 10,000 $ 1
May 20, 1999 5,000 $ 31/32
May 25, 1999 13,400 $ 1
</TABLE>
Except for the purchases noted in the schedule above, Mr.
Kolow has not engaged in any other transactions involving the
Common Stock in the past sixty (60) days.
<PAGE> 6
Page 5 of 5 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
May 28, 1999
---------------------------
(Date)
/s/ Steven M. Kolow
---------------------------
(Signature)
Seven M. Kolow
---------------------------
(Name/Title)
